• 1. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 2. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 3. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782

Comprehensive Overview of 1-(3-Fluorobenzyl)-1H-pyrazol-5-amine (CAS No. 1015845-94-9)

1-(3-Fluorobenzyl)-1H-pyrazol-5-amine (CAS No. 1015845-94-9) is a fluorinated pyrazole derivative that has garnered significant attention in pharmaceutical and agrochemical research. This compound belongs to the class of heterocyclic amines, which are widely studied for their diverse biological activities. The presence of a fluorobenzyl group at the 1-position and an amine group at the 5-position of the pyrazole ring makes it a versatile intermediate for drug discovery and material science applications.

The molecular structure of 1-(3-Fluorobenzyl)-1H-pyrazol-5-amine features a pyrazole core, a five-membered aromatic ring with two nitrogen atoms. The 3-fluorobenzyl substituent enhances the compound's lipophilicity, potentially improving its bioavailability in drug formulations. Researchers have explored its utility in designing kinase inhibitors, antimicrobial agents, and central nervous system (CNS) modulators, aligning with current trends in precision medicine and targeted therapies.

In recent years, the demand for fluorinated organic compounds like 1-(3-Fluorobenzyl)-1H-pyrazol-5-amine has surged due to their unique physicochemical properties. Fluorination often improves metabolic stability and binding affinity in drug candidates, making this compound a valuable building block in medicinal chemistry. Its applications extend to crop protection chemicals, where fluorinated pyrazoles are used to develop next-generation pesticides with enhanced efficacy and environmental safety.

The synthesis of 1-(3-Fluorobenzyl)-1H-pyrazol-5-amine typically involves multi-step organic reactions, including N-alkylation of pyrazole derivatives with 3-fluorobenzyl halides. Advanced purification techniques such as column chromatography and recrystallization ensure high purity, which is critical for research and industrial applications. Analytical characterization via NMR spectroscopy, mass spectrometry, and HPLC confirms its structural integrity.

From a commercial perspective, 1-(3-Fluorobenzyl)-1H-pyrazol-5-amine is supplied by specialized chemical manufacturers catering to the pharmaceutical and agrochemical sectors. Its market growth is driven by the rising investment in small-molecule drug development and sustainable agriculture. Regulatory compliance with REACH and FDA guidelines ensures its safe handling and usage in laboratories and production facilities.

Emerging research highlights the potential of 1-(3-Fluorobenzyl)-1H-pyrazol-5-amine in cancer therapeutics, particularly as a scaffold for tyrosine kinase inhibitors. Its ability to modulate protein-protein interactions aligns with the growing interest in targeted cancer therapies. Additionally, its role in neuroprotective agents is being investigated, addressing global health challenges like neurodegenerative diseases.

For researchers and industry professionals, understanding the structure-activity relationship (SAR) of 1-(3-Fluorobenzyl)-1H-pyrazol-5-amine is crucial. Computational tools like molecular docking and QSAR modeling are employed to predict its interactions with biological targets. These approaches accelerate the discovery of novel applications while reducing experimental costs.

In summary, 1-(3-Fluorobenzyl)-1H-pyrazol-5-amine (CAS No. 1015845-94-9) represents a promising compound at the intersection of medicinal chemistry and agrochemical innovation. Its fluorinated structure, synthetic versatility, and broad applicability position it as a key player in advancing life sciences and sustainable technologies. Future studies may unlock further potential in personalized medicine and green chemistry initiatives.

• 3528-51-6(2-benzylpyrazol-3-amine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)